Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells

被引:81
作者
Chaudhuri, Devyani
Orsulic, Sandra
Ashok, Badithe T.
机构
[1] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
关键词
D O I
10.1158/1535-7163.MCT-06-0404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epidemiologic studies show a correlation between increased consumption of fruits and vegetables with reduced risk of ovarian cancer. One major bioactive compound found in cruciferous vegetables, particularly broccoli, is sulforaphane, derived from the breakdown of glucoraphanin. We observed potent anti proliferative effects of sulforaphane on human ovarian cancer cell line SKOV3 (IC50 40 mu mol/L) and mouse ovarian cancer cell lines C3 and T3 (IC50 25 mu mol/L each) by cell viability assays. The loss of viability is reflected by a downregulation of cell cycle transition regulators cyclin D1, cyclin-dependent kinase 4 (cdk4), and cdk6. The upstream mediators of sulforaphane effects on the cell cycle in ovarian cancer are still unknown. However, because the Akt signal transduction pathway is overactivated in ovarian cancer, we investigated the effects of sulforaphane on this prosurvival pathway. Both total Akt protein and active phosphorylated levels of Akt (Ser(473)) and phosphoinositide 3-kinase were significantly decreased in sulforaphane-treated SKOV3, C3, and T3 cells with a concomitant inhibition of Akt kinase activity by sulforaphane in SKOV3 and C3 cells. This inhibitory effect of sulforaphane leads to a potent induction of apoptosis in all three cell lines, along with the cleavage of poly(ADP)ribose polymerase. Our study is the first to report the antiproliferative effects of sulforaphane in ovarian cancer and identifying the Akt pathway as a target of sulforaphane, with implications for the inhibition of carcinogenesis by diet-based chemoprevention.
引用
收藏
页码:334 / 345
页数:12
相关论文
共 36 条
[11]   Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer [J].
Dinulescu D.M. ;
Ince T.A. ;
Quade B.J. ;
Shafer S.A. ;
Crowley D. ;
Jacks T. .
Nature Medicine, 2005, 11 (1) :63-70
[12]   G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells [J].
Gao, N ;
Flynn, DC ;
Zhang, Z ;
Zhong, XS ;
Walker, V ;
Liu, KJ ;
Shi, XL ;
Jiang, BH .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (02) :C281-C291
[13]   Synthetic dimer of indole-3-carbinol: Second generation diet derived anti-cancer agent in hormone sensitive prostate cancer [J].
Garikapaty, VPS ;
Ashok, BT ;
Tadi, K ;
Mittelman, A ;
Tiwari, RK .
PROSTATE, 2006, 66 (05) :453-462
[14]   Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines [J].
Holmes, WF ;
Soprano, DR ;
Soprano, KJ .
JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 199 (03) :317-329
[15]   In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat [J].
Hu, R ;
Hebbar, V ;
Kim, BR ;
Chen, C ;
Winnik, B ;
Buckley, B ;
Soteropoulos, P ;
Tolias, P ;
Hart, RP ;
Kong, ANT .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (01) :263-271
[16]  
*IARC WORK GROUP, 2003, IARC HDB CANC PREV F, V8
[17]   Role of PI3K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells [J].
Jakubíková, J ;
Sedlák, J ;
Mithen, R ;
Bao, YP .
BIOCHEMICAL PHARMACOLOGY, 2005, 69 (11) :1543-1552
[18]   Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas [J].
Kurose, K ;
Zhou, XP ;
Araki, T ;
Cannistra, SA ;
Maher, ER ;
Eng, C .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (06) :2097-2106
[19]   Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apcmin mice [J].
Myzak, MC ;
Dashwood, WM ;
Orner, GA ;
Ho, E ;
Dashwood, RH .
FASEB JOURNAL, 2006, 20 (01) :506-+
[20]   Chemoprotection by sulforaphane: Keep one eye beyond Keap1 [J].
Myzak, MC ;
Dashwood, RH .
CANCER LETTERS, 2006, 233 (02) :208-218